Accessible care · Continuous support

Integrated, community-based care to prevent and treat STBBIs

Since 2019, Métropoles Sans Hep C has brought together community, clinical, academic and public health partners to improve access to hepatitis C testing and treatment in Montréal.

We want to build on this experience to develop integrated care pathways for sexually transmitted and blood-borne infections (STBBIs), connected with harm reduction and addiction care. The aim: to reach people who face barriers to accessing services and to support them from testing through treatment and follow-up.

Métropoles Sans Hep C logo
The problem

From testing to treatment, too many chances to lose contact

Testing is not enough if the person does not receive their result, cannot access treatment or loses contact with the team. Travel, multiple appointments and housing instability can interrupt this pathway. Our work with people with lived experience highlights the importance of services that are accessible where they live, clear information and continuous support.

Context: 5,036 people experiencing visible homelessness in Montréal at the point-in-time count of April 15, 2025 (preliminary results; MSSS, Tout le monde compte 2025).

The proposed care pathway

What “integrated care” means for a person

A single pathway connects STBBI prevention, testing, treatment and follow-up. Services are offered on site where possible, with support to reach partner services where needed.

1

Reach

Go to people in community organizations, shelters and the other places they use, with peers and flexible ways of welcoming them.

2

Treat

Offer STBBI prevention and testing, then facilitate confirmation of the diagnosis and access to treatment. Connect this care with harm reduction and addiction services, as needed.

3

Support

A designated contact person helps people get their results, arrange appointments and access medication. They maintain the link between the person, the organization, the pharmacy and the clinical team.

4

Improve

Measure the number of people reached, tests performed, time to treatment and retention in care, as well as people's experience and the resources required.

My treatment was easy… I was staying at OBM [Old Brewery Mission] and they asked me if I had Hep C and I said yes I do and they said we can do something about that and a week later I was taking a pill.

More testimonials

I kind of lost the apartment… I thought it was a shame because I could have kept going with it [treatment], but like, I didn't get the support I wanted or hoped for…

There's a way to treat them properly. That's the difference between the nurses here [supervised injection site] and at the hospital. These guys know what's up. They've been around the population; the way they treat you is completely differently. Confidentiality, respect…

What the proposal builds on

Field interventions supported by research

The proposal builds on interventions carried out with the coalition's partners and on the cohorts and databases of its research teams. Together, this work makes it possible to identify gaps in care and to evaluate ways of addressing them.

Intervening in community settings

2024-2025

Re-engagement in care (RELIER-VHC)

Tested for 18 months with Montréal public health, the intervention that reconnects people who were diagnosed and then lost to follow-up has been part of its routine activities since December 2025.

2024-2026

Integrating care into community settings

CADRE-C, PHARMA-C+ and SCALE-POCT help develop and evaluate community-based hepatitis C testing, in community organizations and pharmacies, and linkage to treatment.

Measuring: the research teams' cohorts and databases

1990-2025

Linked administrative data

Linked administrative databases from Québec make it possible to measure the burden of infectious diseases (HIV, hepatitis B, hepatitis C), health outcomes and the pathway from testing to treatment.

With people with lived experience

People who use the services contribute to the coalition in three ways: in design, through the consultations and interviews that set priorities for access to care; in delivery, with a community peer navigator on the team; and in evaluation, through interviews about their experience of services.

Who is building the model

Leadership shared across four sectors

Community sector

CAPAHC sits on the co-directorate; partner organizations host the teams and deliver testing.

Clinical settings

MUHC, CHUM and Jewish General Hospital: viral infections, addiction medicine, migrant health, and the health of Indigenous people in vulnerable situations.

Public health

Montréal public health integrates proven interventions into its activities.

Research

McGill University (RISE³), Université de Montréal (HEPCO) and the Lady Davis Institute of the Jewish General Hospital (linked databases): measuring outcomes and implementation conditions.

See the team and partners

The next step

Deploy and evaluate an integrated STBBI care pathway in Montréal

Proposal in preparation with partners. Sites, timeline and funding to be confirmed.

We propose a deployment in three to five Montréal settings starting in 2027. The support sought would strengthen on-site STBBI care, support between services and the evaluation of results, building on existing organizations and teams.

Building the deployment with public partners

We wish to agree on participating sites, clinical responsibilities, funding and outcome targets for 2027–2030. The evaluation will guide the continuation of the model and its adaptation to other settings in Québec.

Sources
  • Ministère de la Santé et des Services sociaux (Québec). Tout le monde compte 2025 : l'itinérance visible au Québec et son évolution, résultats préliminaires (point-in-time count of April 15, 2025; in French).
  • CATIE. What does it take to eliminate hepatitis C in a city like Montreal? Blog post by the MSHC team, May 25, 2026.
  • Kleiner BB et al. Incidence of HIV and HCV among people who inject drugs in Montreal, Canada: data from the HEPCO longitudinal cohort study, 2011-2025. J Viral Hepat 2026.